baber/WOPTO huggingface dataset:
Patent NZ-243959-A (NZ)
Title: Substituted pyrazine derivatives and pharmaceutical compositions thereof
Inventor: KOPPE HERBERT
IPC: C07D241/34
Filed: 1992-08-14
Abstract: Disclosed are new compounds of formula (I) (R<1> to R<6> being defined in the description) which can be prepared by conventional methods. The compounds are suitable for use as active ingredients in drugs.
Patent NZ-303861-A (NZ)
Title: Amino acid hydroxyethylamine sulphonamide derivatives as protease inhibitors
Inventor: GETMAN DANIEL P
IPC: A61P31/18
Filed: 1996-03-07
Abstract: Selected amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
Patent NZ-330474-A (NZ)
Title: Article carrier with strap type handle and top panel access
Inventor: RANDALL HARRIS L
IPC: B65D71/00
Filed: 1997-11-18
Abstract: n article carrier (10) is disclosed having an elongated handle strap (22) and a tear-away top opening feature.
Patent NZ-333220-A (NZ)
Title: Providing anonymous data transfer in GSM mobile phone system by authenticating mobile station without using unique identifier
Inventor: BILLSTROM LARS AXEL
IPC: H04L9/32
Filed: 1997-06-06
Abstract: A communication station, such as a mobile phone 12 is provided with anonymous access to a communication network such as a GSM mobile phone network.  The station is given a group identifier that identifies the station as being a member of a group entitled to use the network, the stations in the group not having unique identifiers.  Each station stores the group identifier and an associated authentication key.  When the station wishes to communicate it sends an attach request which includes the group identifier.  The station is allocated a network generated random number which is transmitted to the station and used to generate a response based on the random number and authentification key.  This response is compared with a network generated response, and if the two responses match, the station is allocated a temporary mobile station identifier, and allowed to communicate with the network.  The system is disclosed in association with a system for monitoring traffic movements using packet radio communication.  The system preserves privacy, as the identity of the station is not known to the system.
Patent NZ-502471-A (NZ)
Title: Comprises of a softening stage and a curing stage to prepare cellulosic fibrous aggregate (hemicellulose) for anaerobic purification
Inventor: GROENEVELD HENDRIK ADRIAAN COR
IPC: D21C3/22
Filed: 2000-01-21
Abstract: A process for the preparation of a cellulosic fibrous aggregate, comprising a softening (hydrothermolysis) stage and a curing stage, whereby in the softening stage a section of cellulosic fibrous material is exposed to the action of a liquid aqueous softening agent at an elevated temperature and at a pressure of at least the equilibrium vapour pressure of the softening agent at the operating temperature, in which at least part of an aqueous stream, contaminated with organic material, obtained as effluent stream from the zone wherein the softening has been effected, is subjected to an anaerobic purification treatment and at least part of the resulting purified aqueous stream is recycled to the hydrothermolysis stage.
Patent NZ-503581-A (NZ)
Title: Dimmer circuit for light, leading edge of square wave control pulses synchronised with zero-crossing of AC supply
Inventor: HAYASHI KOICHI
IPC: H02M5/293
Filed: 2000-03-23
Abstract: A dimmer circuit for electric lamp (10) includes two solid-state switching devices (12, 13) which are biased into conduction by pulses from square wave generator (15). The square wave generator (15) is controlled by zero-crossing detector (18), so that the leading edge of the square wave is synchronized with the zero-crossing point of the AC supply (11). Capacitors (21 to 24) are wired as a low pass filter to filter out higher-order harmonics in the square wave signal.  The brightness of the lamp is varied by varying the pulse width of the square wave-biasing signal.
Patent NZ-507922-A (NZ)
Title: Process for microgel preparation having a crosslinked polymeric core and a multiplicity of appended polymeric arms
Inventor: SOLOMON DAVID HENRY
IPC: C09J151/00
Filed: 1999-05-07
Abstract: A process for preparing a microgel composition comprises: (i) providing a living prepolymer comprising a linear prepolymer and a radical-terminating group adapted to reversibly cleave from the linear prepolymer under activating conditions to provide a reactive linear prepolymer radical wherein the linear prepolymer portion of the living prepolymer comprises a polymeric chain of at least 3 monomer units; and (ii) polymerizing the living prepolymer under activating conditions with a monomer composition comprising a multi-olefinic cross-linking monomer to provide microgel particles comprising a cross-linked polymer core formed from the monomer composition and a multiplicity of linear arms appended to the core the arms being formed from the linear polymer portion of the living prepolymer wherein the radical terminating group is not alkoxyamine.
Patent NZ-514965-A (NZ)
Title: Apparatus and method for treating ammoniated meats
Inventor: ROTH ELDON
IPC: A23L13/60
Filed: 2000-04-03
Abstract: An initial comminuted meat product (21) is exposed to ammonia to produce an ammoniated meat product. The ammoniated meat product is further comminuted in a comminuting device (12) to produce a further comminuted meat product (22). The ammonia exposure to the original comminuted meat product (21) is controlled to result in a pH of at least around 6.0 in the further comminuted meat product (22).
Patent NZ-517372-A (NZ)
Title: Human monoclonal antibodies to HER2/neu
Inventor: KELER TIBOR
IPC: A61K39/395
Filed: 2000-07-25
Abstract: Isolated human monoclonal antibodies and antigen-binding portions thereof which specifically bind to HER2/neu are disclosed. Also disclosed are bi- and multispecific molecules including human monoclonal antibodies and antigen-binding portions thereof which specifically bind to HER2/neu. The human antibodies can be produced in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent NZ-518477-A (NZ)
Title: Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo
Inventor: DEVAUX BRIGITTE
IPC: C12N1/21
Filed: 2000-10-27
Abstract: Described are isolated anti-prostate stem cell antigen (PSCA) antibodies that internalize upon binding to PSCA on a mammalian in vivo. Compositions comprising an anti-PSCA antibody and a carrier are also provided. These compositions can be contained in an article of manufacture or a kit. Another aspect described is an isolated nucleic acid encoding an anti-PSCA antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PSCA antibodies, and a method of producing the anti-PSCA antibodies. Other aspects include a method of killing a PSCA-expressing cancer cell, comprising contacting the cancer cell with an anti-PSCA antibody and a method of alleviating or treating a PSCA-expressing cancer in a non-human mammal, comprising administering a therapeutically effective amount of the anti-PSCA antibody to the mammal.
Patent NZ-523901-A (NZ)
Title: Purification of air
Inventor: HALL PHILIP
IPC: A61L9/00
Filed: 2001-07-11
Abstract: An air purification system for purifying recirculated air eg in an aircraft, vehicle, offices or hospitals comprises the combination of a filter section with an ultraviolet illumination section and a coating of an antimicrobial agent on surfaces in one or both of the filter and illumination sections. Air flow through the illumination section is caused to be slightly turbulent by means of a multi-bladed fan being fixed in position between the filter and illumination sections. This increases the dwell time of contaminants in the illumination section.
Patent NZ-529004-A (NZ)
Title: Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
Inventor: OPITZ KLAUS
IPC: C07D491/048
Filed: 2002-04-18
Abstract: Disclosed is the use of galanthamine, as free base or as acid addition salt, for the manufacture of a medicament for the treatment of cognitive disorders occurring as sequelae to occasional or chronic use or abuse of hallucinogenic substances, or in cases of acute poisoning, or in cases of chronic exposure to poisons in humans.
Patent NZ-529308-A (NZ)
Title: Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
Inventor: ASHLEY ROBERT A
IPC: A61K9/22
Filed: 2002-04-05
Abstract: A composition is provided for delivering a tetracycline compound to a mammal. The composition includes an antibiotic tetracycline compound and a controlled-release agent. The tetracycline compound is associated with the controlled- release matrix to provide a release profile whereby the mammal is treated substantially without antibiotic activity. The use of such a composition for treating a mammal with a tetracycline compound and a dosage unit are also provided utilising the controlled-release tetracycline composition.
Patent NZ-537730-A (NZ)
Title: Predictive analysis system and method
Inventor: CHARGE ANTHONY
IPC: A63B69/00
Filed: 2003-06-30
Abstract: A method of coaching a sporting team or individual participants during a sporting event is disclosed. The method includes the steps of (a) generating quantitative data (11) relating to performance in previous sporting events, (b) generating quantitative data (12) relating to performance during the sporting event, (c) generating qualitative data (13, 14) relating to the sporting event, and (d) analysing the generated quantitative data (11, 12) and qualitative data (13, 14) in a computer controlled system (20). The generated quantitative and qualitative data is analysed in accordance with a program which includes a risk management methodology (21) to generate an output (30) of predicted strategic significance in the future conduct of the sporting event.
Patent NZ-538216-A (NZ)
Title: Treatment and prophylaxis with 4-1BB-binding agents
Inventor: CHEN LIEPING
IPC: A61P9/04
Filed: 2003-07-14
Abstract: Disclosed is the use of a 4-1BB antibody or ligand for the manufacture of a medicament for the treatment of lymphoproliferative disorders wherein the ligand or antibody is effective to induce the death of a double negative T cell.
Patent NZ-539643-A (NZ)
Title: KSP inhibitors of formula I that can be used to treat cellular proliferative disease
Inventor: QIAN XIANGPING
IPC: C07D249/12
Filed: 2003-10-02
Abstract: A compound of Formula I that can be used for the treatment of cellular proliferative diseases by inhibiting the activity of KSP.
Patent NZ-540379-A (NZ)
Title: Novel alkyne compounds having an MCH antagonistic effect and medicaments containing these compounds
Inventor: MUELLER STEPHAN G
Filed: 2003-10-25
Abstract: Disclosed are alkyne compounds of general formula (I) and medicaments containing at least one of these alkyne compounds. Their MCH receptor antagonistic effect renders the medicaments suitable for treating metabolic disorders and/or eating disorders, in particular, obesity, bulimia, anorexia, hyperphagia and diabetes.
Patent NZ-540460-A (NZ)
Title: Glue line use of bifenthrin in wood products
Inventor: ROMERO JAVIER
IPC: A01N53/00
Filed: 2003-12-05
Abstract: Disclosed is a glue, glue line resin system and wood products incorporating glues with bifenthrin where the glue is used for controlling pests that attack wood or wood products, and comprises a resin and a formulation of bifenthrin wherein the bifenthrin the formulation is present in particles of 1 micrometre or larger.
Patent NZ-542253-A (NZ)
Title: Adjuvanted bovine vaccines
Inventor: CHU HSIEN-JUE
IPC: A61K39/00
Filed: 2004-03-05
Abstract: Disclosed is a safe and effective vaccine composition against E. coli 0157:H7 shedding. An immunogenically active component E. coli 0157:H7, a metabolizable oil adjuvant, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine. The invention also provides a method for the prevention or amelioration of E. coli 0157:H7 shedding.
Patent NZ-543696-A (NZ)
Title: Building article, typically roofing panel, with pre-determined density and ratio of moduli of rupture to elasticity
Inventor: BRUNTON GREG
IPC: E04D1/16
Filed: 2004-06-21
Abstract: A durable, "nailable", lightweight and fire resistant fiber cement article is disclosed that can be a cost-effective substitute for conventional building materials is provided. The fiber cement article can be profiled to resemble a roofing article such as a wood shake or slate. The fiber cement article incorporates a hydrophobe and a viscosity enhancing agent that are each selected to control the rate of hydration of the binder. The fiber cement article is durable, is "walkable" and "nailable" without cracking during installation and maintains walkablilty after exposure in service.
Patent NZ-544439-A (NZ)
Title: Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom
Inventor: REGINA AHMED
IPC: A23L7/109
Filed: 2004-06-30
Abstract: Discloses the grain obtained from a wheat plant comprising starch and a null mutation of a starch branching enzyme IIa (SBEIIa) gene or an introduced nucleic acid which encodes an inhibitor of SBEIIa gene expression, wherein the proportion of amylose in the starch of the grain is at least 30% (w/w).
Patent NZ-544764-A (NZ)
Title: A monitoring system
Inventor: MCGEORGE JEFFREY BRUCE
IPC: G06Q50/34
Filed: 2004-06-18
Abstract: A method of monitoring changes in an information set of wagers placed on the outcome of a sporting contest comprises a principal entering into an agreement with a service provider to provide real time activity monitoring service. The principal defines at least one parameter about the information set for at least one change in the information set about which the principal wishes to be alerted. The service provider monitors a predetermined information set in real time according to the principal's at least one parameter using at least one computer. The service provider provides a real-time alert message to the principal via a remote communications device (RCD) when the at least one change occurs according to the principal's at least one parameter.
Patent NZ-548499-A (NZ)
Title: Crystalline polymorphs of a CXC-chemokine receptor ligand
Inventor: HU MENGWEI
IPC: A61K31/34
Filed: 2005-01-28
Abstract: Disclosed is a crystalline polymorph of a monohydrate of Compound A wherein, said polymorph is selected from the group consisting of: Form I that exhibits a powder x-ray diffraction pattern substantially the same as the pattern shown in FIG 1; Form II that exhibits a powder x-ray diffraction pattern substantially the same as the pattern shown in FIG 2; Form III that exhibits a powder x-ray diffraction pattern substantially the same as the pattern shown in FIG 3; and Form IV that exhibits a powder x-ray diffraction pattern substantially the same as the pattern shown in FIG 4. Also disclosed is the use of one of the above polymorphs of Compound A in the manufacture of a medicament for treating a chemokine-mediated disease or condition.
Patent NZ-549665-A (NZ)
Title: Caspase inhibitors and uses thereof
Inventor: STUDLEY JOHN R
IPC: A61K31/401
Filed: 2005-02-28
Abstract: Disclosed are compounds of formula I, wherein the substituents are as defined in the specification, processes for their preparation and intermediates for use therein. The compounds are caspase inhibitors useful in the treatment of IL-1 mediated diseases.
Patent NZ-550435-A (NZ)
Title: Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
Inventor: HORVATH STEPHANE
Filed: 2006-10-10
Abstract: A process for the preparation of the delta-crystalline form of ivabradine hydrochloride of formula (I) is disclosed, wherein acetonitrile or a mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, the solution obtained is allowed to cool at room temperature, held at room temperature until crystallisation is complete, and the crystals formed are collected. This delta-crystalline form of ivabradine hydrochloride is suitable as a bradycardic and is used in the manufacture of medicaments which are of use in the treatment or prevention of various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarct and associated rhythm disturbances, and also in various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in heart failure.
Patent NZ-550563-A (NZ)
Title: Improvements in spray freeze drying
Inventor: CARSON JAMES KENNETH
Filed: 2006-10-16
Abstract: Methods and apparatus are disclosed for drying or concentrating a raw material (3) that has solid and aqueous portions at ambient conditions. The apparatus (1) includes a chamber (2), a device (15) for reducing the chamber pressure, an inlet nozzle (10) for injecting raw material into the chamber, and at least one collection surface (8) that collects a frozen portion (4) of the raw material. The chamber is maintained at a pressure below the triple-point pressure of the aqueous portion, to cause the injected raw material to separate into a frozen portion (4) and an evaporated portion (5A, 5B). The thickness of the accumulated layer of the frozen portion on the collection surface is controlled by at least one parameter selected from; the raw material inlet flow rate; use of positive inlet pressure; inlet nozzle size and configuration; and/or the distance between the inlet nozzle outlet and the collection surface.
Patent NZ-550605-A (NZ)
Title: Cell culture comprising human PDX1-positive foregut endoderm cells
Inventor: D AMOUR KEVIN ALLEN
IPC: C12N5/00
Filed: 2005-04-26
Abstract: Disclosed are cell cultures comprising human PDX1-positive endoderm cells and methods of producing the same. Also disclosed are cell populations comprising substantially purified human PDX1-positive endoderm cells as well as methods for enriching, isolating and purifying PDX1-positive endoderm cells from other cell types. Methods of identifying differentiation factors capable of promoting the differentiation of endoderm cells, such as PDX1-positive foregut endoderm cells and PDX1-negative definitive endoderm cells, are also disclosed.
Patent NZ-550966-A (NZ)
Title: Anti-skimming card reader surface configuration
Inventor: RAKOFF STEVEN BARNETT
IPC: G06V30/224
Filed: 2005-05-03
Abstract: A card reading device, comprising: a housing (20) having an exterior surface at least partially in a plane; a notch (50) that has a depth beyond the plane and a dimension for receiving at least a portion of a finger; a slot (46) at least partially within the housing for receiving a card and having a first portion (52) aligned with the notch and a second portion (54) adjacent to the notch; and an electronic reader (60) directly aligned with the notch in a direction of card insertion into the slot such that when a card is inserted within the slot, some of the card is covered by the second portion of the slot and another portion of the card including a machine readable portion is at least partially covered by the first portion of the slot and accessible from outside the housing.
Patent NZ-555389-A (NZ)
Title: Closed type impeller wheel with leading edges of vanes swept back
Inventor: LINDSKOG MARTIN
IPC: F04D29/24
Filed: 2005-11-03
Abstract: The present disclosure relates to a pump impeller of a centrifugal or half axial type to be used in a pump for pumping liquids, wherein the impeller is arranged with one or several vanes (18), that the vanes are attached to cover discs (16) on each side, forming a so called closed impeller wheel, characterized in that the leading edges (40) of the vanes are swept backwards at the inlet opening (42) in one of the cover discs (16) of the impeller.
Patent NZ-555994-A (NZ)
Title: Tetrahydroquinoline analogues as muscarinic agonists
Inventor: SKJAERBAEK NIELS
IPC: A61K31/4709
Filed: 2005-12-15
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. Embodiments of the compound are shown in Fig 2. The compounds are agonists of cholinergic receptors, especially the M1- and M4 subtype of muscarinic receptors, useful in the treatment of conditions associated with cognitive impairment.
Patent NZ-560639-A (NZ)
Title: A method and means of applying adhesive tape
Inventor: BRADLEY JOHN DARCY
Filed: 2004-08-13
Abstract: An applicator head is disclosed for the application of adhesive to first and second surfaces for joining together, with the applicator head being connectable with the non-adhesive side of the tape via a pair of rotatable rollers maintained for relative movement whereby relative offsetting can occur.
Patent NZ-563740-A (NZ)
Title: Process for the synthesis of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide
Inventor: MCKENNA JOSEPH
IPC: C07D213/56
Filed: 2006-06-07
Abstract: Disclosed is a process for the preparation of compounds of formula (I), which comprises reacting a 4-substituted-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl ester derivative with R1-NH-R2, in an organic solvent (such as tetrahydrofuran, dimethylformamide, toluene or N-methylpyrrolidone) and wherein the process is catalysed by a base (such as potassium tert-butoxide); wherein R1 is substituted or unsubstituted aryl; R2 is hydrogen, lower alky or aryl; and R4 is hydrogen, lower alkyl or halogen. Also disclosed is the use of the above process for the synthesis of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide.
Patent NZ-565196-A (NZ)
Title: System and method for dry cleaning articles using siloxane solvent
Inventor: DOUGLAS JAMES E
IPC: D06F43/00
Filed: 2006-06-19
Abstract: A method of dry cleaning articles comprising: inserting articles to be cleaned into a cleaning basket of a dry cleaning machine; immersing the articles to be cleaned in a cleaning fluid comprising a siloxane solvent composition; agitating the articles in the siloxane solvent composition; filtering the siloxane solvent composition through at least one regenerative filter, said regenerative filter having being regenerated by pre-coating with a first coating comprising an activated clay; removing the siloxane composition from the articles; and regenerating said filter at a periodic time basis by removing said first coating and pre-coating said regenerative filter with a second coating comprising an activated clay for preventing oligomerization of at least one of said first coating activated clay and said solvent.